` PUR (Pure Biologics SA) vs WIG20 Comparison - Alpha Spread

P
PUR
vs
W
WIG20

Over the past 12 months, PUR has underperformed WIG20, delivering a return of -65% compared to the WIG20's +28% growth.

Stocks Performance
PUR vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PUR vs WIG20

Loading
PUR
WIG20
Difference
www.alphaspread.com

Performance By Year
PUR vs WIG20

Loading
PUR
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Pure Biologics SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Pure Biologics SA
Glance View

Market Cap
32.9m PLN
Industry
Biotechnology

Pure Biologics SA is a biopharmaceutical company, which engages in the research and development of innovative biological medicines and medical devices for use therapeutic and diagnostic tests. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 101 full-time employees. The company went IPO on 2018-12-11. The firm was founded in August 2010 and is located in Wroclaw, Poland.

PUR Intrinsic Value
0.02 PLN
Overvaluation 99%
Intrinsic Value
Price
P
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett